Table 3 |
|||||
|
Clinical efficacy of SF versus NF after period 1 |
|||||
|
SF (n = 15) |
NF (n = 20) |
Difference of means (95% CI)* |
RR (95% CI)** |
P-value |
|
|
|
|||||
|
Defecation frequency (mean ± SD) |
4.9 ± 2.5 |
5.6 ± 2.8 |
0.7 (-0.8–2.3) |
0.36 |
|
|
Improvement of hard to soft stools (n) |
50% (5/10) |
90% (9/10) |
1.8 (0.9–3.5) |
0.14 |
|
|
No painful defecation (n) |
33% (5/15) |
35% (7/20) |
1.0 (0.4–2.7) |
0.92 |
|
|
No abdominal or rectal mass (n) |
93% (14/15) |
90% (18/20) |
1.0 (0.8–1.2) |
0.73 |
|
|
|
|||||
|
* ANCOVA; ** χ2 tests |
|||||
|
Bongers et al. Nutrition Journal 2007 6:8 doi:10.1186/1475-2891-6-8 |
|||||
